Treace Medical Concepts (TMCI) Long-Term Debt Repayments (2021 - 2022)
Treace Medical Concepts posted quarterly Long-Term Debt Repayments of -$33.9 million for Q4 2022, down 200.0% on a QoQ basis from $33.9 million in Q2 2022.
Treace Medical Concepts (TMCI) has 2 years of Long-Term Debt Repayments data on file, last reported at -$33.9 million in Q4 2022.
- For the quarter ending Q4 2022, Long-Term Debt Repayments changed N/A year-over-year to -$33.9 million; the trailing twelve-month figure through Dec 2023 stood at -$33.9 million (changed N/A YoY), and the FY2021 full-year result was $1.8 million, changed N/A from the prior year.
- Long-Term Debt Repayments for Q4 2022 stood at -$33.9 million, down from $33.9 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $33.9 million in Q2 2022 and bottomed at -$33.9 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Treace Medical Concepts | 234.79 Mn | 182.94 Mn | 37.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -33.89 Mn |
| Dec 31, 2022 | -33.89 Mn |
| Jun 30, 2022 | 33.89 Mn |
| Jun 30, 2022 | 33.89 Mn |
| Mar 31, 2021 | 1.79 Mn |
| Mar 31, 2021 | 1.79 Mn |